Europe Exosome Research Products Market - Industry Trends And Forecast To 2030

Description

List of Tables

Europe exosome research products market is projected to register a substantial CAGR of 33.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation:

Europe Exosome Research Products Market By Product (Instruments and Consumables), Indication (Cancer and Non-Cancer), Application (Therapeutics and Diagnosis), End Users (Hospitals, Clinical Testing Laboratories, Research Centers, Pharmaceutical and Biotechnology Company, Academic Institutes, and Others), Distribution Channel (Third Party Distributors, Online, Direct Tender, and Others), Country (Germany, U.K., France, Italy, Spain, Russia, Switzerland, Netherlands, Turkey, Sweden, Poland, Norway, Belgium, Finland, Denmark, and Rest of Europe) Industry Trends and Forecast to 2030

Market Drivers:

Growing prevalence of cancer, chronic inflammation, autoimmune disease, Lyme disease, and other chronic degenerative diseases

Increasing investments in pharmaceutical R&D and life sciences research

Market Players:

The key market players in Europe colorectal cancer diagnostics market are listed below:

Hologic Inc.

Luminex Corporation

Thermo Fisher Scientific.

Agilent Technologies, Inc.

Cell Guidance Systems LLC

QIAGEN

FUJIFILM Irvine Scientific(a subsidiary of FUJIFILM Holdings Corporation, CUSABIO TECHNOLOGY LLC)

Norgen Biotek Corp.

Miltenyi Biotec

AMSBIO

ExoDx (Acquired By Bio-Techne)

HBMLS (Acquired by Lonza)

Creative Bioarray

NanoSomiX

Novus Biologicals

Beckman Coulter, Inc.

JSR Micro NV

Hitachi, Ltd.

INOVIQ

Audubon Bioscience

1 INTRODUCTION 54

1.1 OBJECTIVES OF THE STUDY 54
1.2 MARKET DEFINITION 54
1.3 OVERVIEW OF THE EUROPE EXOSOME RESEARCH PRODUCTS MARKET 54
1.4 LIMITATIONS 56
1.5 MARKETS COVERED 56

2 MARKET SEGMENTATION 59

2.1 MARKETS COVERED 59
2.2 GEOGRAPHICAL SCOPE 60
2.3 YEARS CONSIDERED FOR THE STUDY 61
2.4 CURRENCY AND PRICING 61
2.5 DBMR TRIPOD DATA VALIDATION MODEL 62
2.6 MULTIVARIATE MODELLING 65
2.7 PRODUCT LIFELINE CURVE 66
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 67
2.9 DBMR MARKET POSITION GRID 68
2.10 MARKET APPLICATION COVERAGE GRID 70
2.11 VENDOR SHARE ANALYSIS 71
2.12 SECONDARY SOURCES 72
2.13 ASSUMPTIONS 72

3 EXECUTIVE SUMMARY 73

4 PREMIUM INSIGHTS 75

4.1 PESTEL ANALYSIS 76
4.2 PORTER'S FIVE FORCES MODEL 77
4.3 SUPPLY CHAIN ANALYSIS 78
4.4 VALUE CHAIN ANALYSIS 79
4.5 BUSINESS STRATEGY EXCELLENCE 80
4.6 CASE STUDIES 81
4.7 STRENGTH OF PRODUCT PORTFOLIO 83
4.8 TECHNOLOGICAL TRENDS 85
4.9 PRICING ANALYSIS 86

5 INDUSTRY INSIGHTS 87

6 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, REGULATIONS 88

7 MARKET OVERVIEW 90

7.1 DRIVERS 92
- 7.1.1 GROWING PREVALENCE OF CANCER, CHRONIC INFLAMMATION, AUTOIMMUNE DISEASE, LYME DISEASE, AND OTHER CHRONIC DEGENERATIVE DISEASES 92
- 7.1.2 INCREASING INVESTMENTS IN PHARMACEUTICAL R&D AND LIFE SCIENCES RESEARCH 92
- 7.1.3 AVAILABILITY OF VARIOUS EXOSOME ISOLATION AND PURIFICATION TECHNIQUES AND PROGRESSING THERAPEUTIC VALUE OF EXOSOME 93
7.2 RESTRAINTS 94
- 7.2.1 LACK OF GOLD STANDARD PROTOCOLS FOR THE DEVELOPMENT AND PRODUCTION OF EXOSOMES 94
- 7.2.2 THE SHORTAGE OF SKILLED PROFESSIONALS REQUIRED FOR THE ISOLATION OF EXOSOME 94
7.3 OPPORTUNITIES 95
- 7.3.1 RISING DEMAND FOR SPECIALIZED TESTING SERVICES AMONG END USERS. 95
- 7.3.2 INCREASING ADVANCEMENT IN EXOSOME TECHNOLOGY 95
- 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 96
7.4 CHALLENGES 97
- 7.4.1 SIDE EFFECTS ASSOCIATED WITH EXOSOME RESEARCH PRODUCTS 97
- 7.4.2 LATE APPROVAL ASSOCIATED WITH PRODUCT LAUNCHES 97

8 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT 98

8.1 OVERVIEW 99
8.2 CONSUMABLES 102
- 8.2.1 KITS AND REAGENTS 103
  - 8.2.1.1 EXOSOME BIOMARKER KITS 104
  - 8.2.1.2 EXOSOME ISOLATION KITS 104
  - 8.2.1.3 EXOSOME PURIFICATION KITS 104
  - 8.2.1.4 EXOSOME QUANTITATIVE KITS 104
  - 8.2.1.5 EXOSOME DETECTION KITS 104
  - 8.2.1.6 OTHERS 104
- 8.2.2 EXOSOME STANDARDS 104
- 8.2.3 EXOSOME ANTIBODIES 104
- 8.2.4 CELL LINES 104
- 8.2.5 IMMUNOPLATES 105
- 8.2.6 IMMUNOBEADS 105
- 8.2.7 BIOFLUIDS 105
- 8.2.8 OTHERS 105
8.3 INSTRUMENTS 105
- 8.3.1 BENCHTOP 106
- 8.3.2 STANDALONE 106

9 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION 107

9.1 OVERVIEW 108
9.2 CANCER 111
- 9.2.1 LUNG CANCER 112
- 9.2.2 BREAST CANCER 112
- 9.2.3 COLORECTAL CANCER 112
- 9.2.4 PROSTATE CANCER 113
- 9.2.5 OTHER CANCER 113
9.3 NON-CANCER 113
- 9.3.1 CARDIOVASCULAR DISEASE 114
- 9.3.2 NEURODEGENERATIVE DISEASE 114
- 9.3.3 INFECTIOUS DISEASE 114
- 9.3.4 OTHERS 114

10 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION 115

10.1 OVERVIEW 116
10.2 THERAPEUTICS 119
10.3 CONSUMABLES 120
10.4 INSTRUMENTS 120
10.5 DIAGNOSIS 120
10.6 CONSUMABLES 121
10.7 INSTRUMENTS 121

11 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 122

11.1 OVERVIEW 123
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY 126
11.3 CONSUMABLES 127
11.4 INSTRUMENTS 127
11.5 RESEARCH CENTRES 127
11.6 CONSUMABLES 128
11.7 INSTRUMENTS 128
11.8 ACADEMIC INSTITUTES 128
11.9 CONSUMABLES 129
11.10 INSTRUMENTS 129
11.11 CLINICAL TESTING LABORATORY 129
11.12 CONSUMABLES 130
11.13 INSTRUMENTS 130
11.14 HOSPITALS 131
11.15 CONSUMABLES 132
11.16 INSTRUMENTS 132
11.17 OTHERS 132

12 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL 133

12.1 OVERVIEW 134
12.2 THIRD PARTY DISTRIBUTORS 137
12.3 DIRECT SALES 137
12.4 ONLINE 138

13 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY REGION 139

13.1 EUROPE 140
- 13.1.1 GERMANY 151
- 13.1.2 U.K. 157
- 13.1.3 FRANCE 163
- 13.1.4 ITALY 169
- 13.1.5 SPAIN 175
- 13.1.6 RUSSIA 181
- 13.1.7 SWITZERLAND 187
- 13.1.8 NETHERLANDS 193
- 13.1.9 TURKEY 199
- 13.1.10 SWEDEN 205
- 13.1.11 POLAND 211
- 13.1.12 NORWAY 217
- 13.1.13 BELGIUM 223
- 13.1.14 FINLAND 229
- 13.1.15 DENMARK 235
- 13.1.16 REST OF EUROPE 241

14 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, COMPANY LANDSCAPE 242

14.1 COMPANY SHARE ANALYSIS: EUROPE 242

15 SWOT ANALYSIS 243

16 COMPANY PROFILE 244

16.1 THERMO FISHER SCIENTIFIC INC. 244
- 16.1.1 COMPANY SNAPSHOT 244
- 16.1.2 REVENUE ANALYSIS 244
- 16.1.3 COMPANY SHARE ANALYSIS 245
- 16.1.4 PRODUCT PORTFOLIO 245
- 16.1.5 RECENT DEVELOPMENT 246
16.2 EXODX (ACQUIRED BY BIO-TECHNE) 247
- 16.2.1 COMPANY SNAPSHOT 247
- 16.2.2 REVENUE ANALYSIS 247
- 16.2.3 COMPANY SHARE ANALYSIS 248
- 16.2.4 PRODUCT PORTFOLIO 248
- 16.2.5 RECENT DEVELOPMENT 248
16.3 MILTENYI BIOTEC 249
- 16.3.1 COMPANY SNAPSHOT 249
- 16.3.2 COMPANY SHARE ANALYSIS 249
- 16.3.3 PRODUCT PORTFOLIO 250
- 16.3.4 RECENT DEVELOPMENTS 250
16.4 LUMINEX CORPORATION 251
- 16.4.1 COMPANY SNAPSHOT 251
- 16.4.2 PRODUCT PORTFOLIO 251
- 16.4.3 RECENT DEVELOPMENT 251
16.5 HOLOGIC, INC. 252
- 16.5.1 COMPANY SNAPSHOT 252
- 16.5.2 REVENUE ANALYSIS 252
- 16.5.3 COMPANY SHARE ANALYSIS 253
- 16.5.4 PRODUCT PORTFOLIO 253
- 16.5.5 RECENT DEVELOPMENTS 253
16.6 AETHLON MEDICAL, INC. (2022) 254
- 16.6.1 COMPANY SNAPSHOT 254
- 16.6.2 PRODUCT PORTFOLIO 255
- 16.6.3 RECENT DEVELOPMENTS 255
16.7 AGILENT TECHNOLOGIES, INC. 256
- 16.7.1 COMPANY SNAPSHOT 256
- 16.7.2 REVENUE ANALYSIS 256
- 16.7.3 PRODUCT PORTFOLIO 257
- 16.7.4 RECENT DEVELOPMENT 257
16.8 AMSBI0 258
- 16.8.1 COMPANY SNAPSHOT 258
- 16.8.2 PRODUCT PORTFOLIO 258
- 16.8.3 RECENT DEVELOPMENT 258
16.9 AUDUBON BIOSCIENCE. 259
- 16.9.1 COMPANY SNAPSHOT 259
- 16.9.2 PRODUCT PORTFOLIO 259
- 16.9.3 RECENT DEVELOPMENT 259
16.10 BECKMAN COULTER, INC 260
- 16.10.1 COMPANY SNAPSHOT 260
- 16.10.2 PRODUCT PORTFOLIO 260
- 16.10.3 RECENT DEVELOPMENT 260
16.11 BIOVISION INC. (ACQUIRED BY ABCAM PLC) 261
- 16.11.1 COMPANY SNAPSHOT 261
- 16.11.2 REVENUE ANALYSIS 261
- 16.11.3 COMPANY SHARE ANALYSIS 262
- 16.11.4 PRODUCT PORTFOLIO 262
- 16.11.5 RECENT DEVELOPMENT 262
16.12 CELL GUIDANCE SYSTEMS LLC 263
- 16.12.1 COMPANY SNAPSHOT 263
- 16.12.2 PRODUCT PORTFOLIO 263
- 16.12.3 RECENT DEVELOPMENTS 263
16.13 CREATIVE BIOARRAY 264
- 16.13.1 COMPANY SNAPSHOT 264
- 16.13.2 PRODUCT PORTFOLIO 264
- 16.13.3 RECENT DEVELOPMENT 264
16.14 CUSABIO TECHNOLOGY LLC 265
- 16.14.1 COMPANY SNAPSHOT 265
- 16.14.2 PRODUCT PORTFOLIO 265
- 16.14.3 RECENT DEVELOPMENTS 265
16.15 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION 266
- 16.15.1 COMPANY SNAPSHOT 266
- 16.15.2 REVENUE ANALYSIS 266
- 16.15.3 PRODUCT PORTFOLIO 267
- 16.15.4 RECENT DEVELOPMENT 267
16.16 HBMLS (ACQUIRED BY LONZA) 268
- 16.16.1 COMPANY SNAPSHOT 268
- 16.16.2 REVENUE ANALYSIS 268
- 16.16.3 PRODUCT PORTFOLIO 269
- 16.16.4 RECENT DEVELOPMENT 269
16.17 HITACHI, LTD. 270
- 16.17.1 COMPANY SNAPSHOT 270
- 16.17.2 REVENUE ANALYSIS 270
- 16.17.3 PRODUCT PORTFOLIO 271
- 16.17.4 RECENT DEVELOPMENT 271
16.18 INOVIQ 272
- 16.18.1 COMPANY SNAPSHOT 272
- 16.18.2 REVENUE ANALYSIS 272
- 16.18.3 PRODUCT PORTFOLIO 273
- 16.18.4 RECENT DEVELOPMENT 273
16.19 JSR MICRO NV 274
- 16.19.1 COMPANY SNAPSHOT 274
- 16.19.2 PRODUCT PORTFOLIO 274
- 16.19.3 RECENT DEVELOPMENT 274
16.20 MICROGENTAS 275
- 16.20.1 COMPANY SNAPSHOT 275
- 16.20.2 PRODUCT PORTFOLIO 275
- 16.20.3 RECENT DEVELOPMENTS 275
16.21 NANOSOMIX 276
- 16.21.1 COMPANY SNAPSHOT 276
- 16.21.2 PRODUCT PORTFOLIO 276
- 16.21.3 RECENT DEVELOPMENT 276
16.22 NEXOSOME-ONCOLOGY 277
- 16.22.1 COMPANY SNAPSHOT 277
- 16.22.2 PRODUCT PORTFOLIO 277
- 16.22.3 RECENT DEVELOPMENTS 277
16.23 NORGEN BIOTEK CORP. 278
- 16.23.1 COMPANY SNAPSHOT 278
- 16.23.2 PRODUCT PORTFOLIO 278
- 16.23.3 RECENT DEVELOPMENTS 278
16.24 NOVUS BIOLOGICALS 279
- 16.24.1 COMPANY SNAPSHOT 279
- 16.24.2 PRODUCT PORTFOLIO 279
- 16.24.3 RECENT DEVELOPMENT 280
16.25 PROTEOGENEX 281
- 16.25.1 COMPANY SNAPSHOT 281
- 16.25.2 PRODUCT PORTFOLIO 281
- 16.25.3 RECENT DEVELOPMENT 281

16.26 QIAGEN 282
- 16.26.1 COMPANY SNAPSHOT 282
- 16.26.2 REVENUE ANALYSIS 282
- 16.26.3 PRODUCT PORTFOLIO 283
- 16.26.4 RECENT DEVELOPMENT 283
16.27 ROOSTERBIO, INC. 284
- 16.27.1 COMPANY SNAPSHOT 284
- 16.27.2 PRODUCT PORTFOLIO 284
- 16.27.3 RECENT DEVELOPMENTS 285
16.28 SYSTEM BIOSCIENCES, LLC. 286
- 16.28.1 COMPANY SNAPSHOT 286
- 16.28.2 PRODUCT PORTFOLIO 286
- 16.28.3 RECENT DEVELOPMENT 286

17 QUESTIONNAIRE 287

18 RELATED REPORTS 290

LIST OF TABLES

TABLE 1 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, PRICING ANALYSIS 61
TABLE 2 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT , 2021-2030 (USD THOUSAND) 76
TABLE 3 EUROPE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 77
TABLE 4 EUROPE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 78
TABLE 5 EUROPE KITS AND REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 78
TABLE 6 EUROPE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
TABLE 7 EUROPE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 81
TABLE 8 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 85
TABLE 9 EUROPE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 87
TABLE 10 EUROPE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 87
TABLE 11 EUROPE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 88
TABLE 12 EUROPE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 89
TABLE 13 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 93
TABLE 14 EUROPE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 94
TABLE 15 EUROPE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 94
TABLE 16 EUROPE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
TABLE 17 EUROPE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 96
TABLE 18 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 100
TABLE 19 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 101
TABLE 20 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 101
TABLE 21 EUROPE RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 102
TABLE 22 EUROPE RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 103
TABLE 23 EUROPE ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 104
TABLE 24 EUROPE ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 104
TABLE 25 EUROPE CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 105
TABLE 26 EUROPE CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 105
TABLE 27 EUROPE HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 106
TABLE 28 EUROPE HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 106
TABLE 29 EUROPE OTHERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 107
TABLE 30 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 111
TABLE 31 EUROPE THIRD PARTY DISTRIBUTORS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 112
TABLE 32 EUROPE DIRECT SALES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 113
TABLE 33 EUROPE ONLINE IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 113
TABLE 34 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 120
TABLE 35 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 120
TABLE 36 EUROPE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 121
TABLE 37 EUROPE KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 121
TABLE 38 EUROPE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 122
TABLE 39 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 122
TABLE 40 EUROPE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 122
TABLE 41 EUROPE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 123
TABLE 42 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 123
TABLE 43 EUROPE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 123
TABLE 44 EUROPE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 123
TABLE 45 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 124
TABLE 46 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 124
TABLE 47 EUROPE RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 124
TABLE 48 EUROPE ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 125
TABLE 49 EUROPE CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 125
TABLE 50 EUROPE HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 125
TABLE 51 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 125
TABLE 52 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 126
TABLE 53 GERMANY CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 126
TABLE 54 GERMANY KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 127
TABLE 55 GERMANY INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 127
TABLE 56 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 127
TABLE 57 GERMANY CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 128
TABLE 58 GERMANY NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 128
TABLE 59 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 128
TABLE 60 GERMANY THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 129
TABLE 61 GERMANY DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 129
TABLE 62 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 129
TABLE 63 GERMANY PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 130
TABLE 64 GERMANY RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 130
TABLE 65 GERMANY ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 130
TABLE 66 GERMANY CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 130
TABLE 67 GERMANY HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 131
TABLE 68 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 131
TABLE 69 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 132
TABLE 70 U.K. CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 132
TABLE 71 U.K. KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 133
TABLE 72 U.K. INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 133
TABLE 73 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 133
TABLE 74 U.K. CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 134
TABLE 75 U.K. NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 134
TABLE 76 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 134
TABLE 77 U.K. THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 135
TABLE 78 U.K. DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 135
TABLE 79 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 135
TABLE 80 U.K. PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 136
TABLE 81 U.K. RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 136
TABLE 82 U.K. ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 136
TABLE 83 U.K. CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 136
TABLE 84 U.K. HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 137
TABLE 85 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 137
TABLE 86 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 138
TABLE 87 FRANCE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 138
TABLE 88 FRANCE KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 139
TABLE 89 FRANCE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 139
TABLE 90 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 139
TABLE 91 FRANCE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 140
TABLE 92 FRANCE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 140
TABLE 93 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 140
TABLE 94 FRANCE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 141
TABLE 95 FRANCE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 141
TABLE 96 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 141
TABLE 97 FRANCE PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 142
TABLE 98 FRANCE RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 142
TABLE 99 FRANCE ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 142
TABLE 100 FRANCE CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 142
TABLE 101 FRANCE HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 143
TABLE 102 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 143
TABLE 103 ITALY EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 144
TABLE 104 ITALY CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 144
TABLE 105 ITALY KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 145
TABLE 106 ITALY INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 145
TABLE 107 ITALY EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 145
TABLE 108 ITALY CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 146
TABLE 109 ITALY NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 146
TABLE 110 ITALY EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 146
TABLE 111 ITALY THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 147
TABLE 112 ITALY DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 147
TABLE 113 ITALY EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 147
TABLE 114 ITALY PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 148
TABLE 115 ITALY RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 148
TABLE 116 ITALY ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 148
TABLE 117 ITALY CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 148
TABLE 118 ITALY HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 149
TABLE 119 ITALY EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 149
TABLE 120 SPAIN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 150
TABLE 121 SPAIN CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 150
TABLE 122 SPAIN KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 151
TABLE 123 SPAIN INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 151
TABLE 124 SPAIN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 151
TABLE 125 SPAIN CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 152
TABLE 126 SPAIN NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 152
TABLE 127 SPAIN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 152
TABLE 128 SPAIN THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 152
TABLE 129 SPAIN DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 153
TABLE 130 SPAIN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 153
TABLE 131 SPAIN PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 153
TABLE 132 SPAIN RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 154
TABLE 133 SPAIN ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 154
TABLE 134 SPAIN CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 154
TABLE 135 SPAIN HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 154
TABLE 136 SPAIN EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 155
TABLE 137 RUSSIA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 156
TABLE 138 RUSSIA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 156
TABLE 139 RUSSIA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 157
TABLE 140 RUSSIA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 157
TABLE 141 RUSSIA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 157
TABLE 142 RUSSIA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 158
TABLE 143 RUSSIA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 158
TABLE 144 RUSSIA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 158
TABLE 145 RUSSIA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 159
TABLE 146 RUSSIA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 159
TABLE 147 RUSSIA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 159
TABLE 148 RUSSIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 160
TABLE 149 RUSSIA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 160
TABLE 150 RUSSIA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 160
TABLE 151 RUSSIA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 160
TABLE 152 RUSSIA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 161
TABLE 153 RUSSIA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 161
TABLE 154 SWITZERLAND EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 162
TABLE 155 SWITZERLAND CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 162
TABLE 156 SWITZERLAND KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 163
TABLE 157 SWITZERLAND INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 163
TABLE 158 SWITZERLAND EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 163
TABLE 159 SWITZERLAND CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 164
TABLE 160 SWITZERLAND NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 164
TABLE 161 SWITZERLAND EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 164
TABLE 162 SWITZERLAND THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 165
TABLE 163 SWITZERLAND DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 165
TABLE 164 SWITZERLAND EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 165
TABLE 165 SWITZERLAND PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 166
TABLE 166 SWITZERLAND RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 166
TABLE 167 SWITZERLAND ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 166

LIST OF FIGURES

FIGURE 1 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION 33
FIGURE 2 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: DATA TRIANGULATION 36
FIGURE 3 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: DROC ANALYSIS 37
FIGURE 4 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 38
FIGURE 5 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS 38
FIGURE 6 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS 41
FIGURE 7 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: DBMR MARKET POSITION GRID 42
FIGURE 8 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: MARKET APPLICATION COVERAGE GRID 44
FIGURE 9 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: VENDOR SHARE ANALYSIS 45
FIGURE 10 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION 48
FIGURE 11 THE INCREASE IN THE PREVALENCE OF CANCER AND OTHER AUTO-IMMUNE DISEASE IS EXPECTED TO DRIVE THE EUROPE EXOSOME RESEARCH PRODUCTS MARKET GROWTH IN THE FORECAST PERIOD 49
FIGURE 12 THE CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE EXOSOME RESEARCH PRODUCTS MARKET IN 2023 & 2030 49
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE EXOSOME RESEARCH PRODUCTS MARKET 65
FIGURE 14 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2022 73
FIGURE 15 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND) 74
FIGURE 16 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, CAGR (2023-2030) 74
FIGURE 17 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE 75
FIGURE 18 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2022 82
FIGURE 19 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2023-2030 (USD THOUSAND) 83
FIGURE 20 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, CAGR (2023-2030) 83
FIGURE 21 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, LIFELINE CURVE 84
FIGURE 22 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2022 90
FIGURE 23 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 91
FIGURE 24 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, CAGR (2023-2030) 91
FIGURE 25 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE 92
FIGURE 26 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2022 97
FIGURE 27 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2023-2030 (USD THOUSAND) 98
FIGURE 28 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, CAGR (2023-2030) 98
FIGURE 29 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, LIFELINE CURVE 99
FIGURE 30 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2022 108
FIGURE 31 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 109
FIGURE 32 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 109
FIGURE 33 EUROPE EXOSOME RESEARCH PRODUCTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE 110
FIGURE 34 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022) 115
FIGURE 35 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022) 116
FIGURE 36 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030) 116
FIGURE 37 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030) 117
FIGURE 38 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030) 118
FIGURE 39 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%) 216